Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-21

Clinical Trial Update: Comparison of Efficacy of Metformin Gel 30% vs Triple Combination Cream (Hydroquinone 4%, Flucinolone Acetonide 0.01%, Tretinoin 0.025%) in Treatment of Melasma in Tertiary Care Hospital Karachi [NA]

View source ↗

Summary

A completed clinical trial comparing metformin gel 30% to a triple-combination cream for the treatment of melasma at a tertiary care center in Karachi.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metformin Gel 30% (Metformin)
  • Triple Combination Cream (Hydroquinone 4%, Flucinolone Acetonide 0.01%, Tretinoin 0.025%)

Snippet

Sponsor: Jinnah Postgraduate Medical Centre | Conditions: Melasma | NA | Status: COMPLETED